Skip to main navigation

About
- Board of Directors
- Leadership Team
Our Science
RNA Programs
Legacy Programs
- Bentrio Nasal Spray
- Inner Ear Therapeutics
Investors & Media

Contact us

About
- Board of Directors
- Leadership Team
Our Science
RNA Programs
Legacy Programs
- Bentrio Nasal Spray
- Inner Ear Therapeutics
Investors & Media

Contact us

Investors & Media

Events & Presentations

Upcoming Events
Past Events
Presentations

Altamira Therapeutics Full Year 2023 Financial Results and Business Update Call

Apr 10, 2024 8:30 AM EDT

Supporting Materials

CYTO FY23 & Business Update Call 1.6 MB

Altamira Therapeutics to Host Investor & Business Update Call

Dec 11, 2023 8:30 AM EST

Supporting Materials

Investor and Business Update Call Presentation 1 MB

Altamira Therapeutics Ltd to hold the Special General Meeting

Oct 31, 2023 8:30 AM CET

Supporting Materials

ALTAMIRA THERAPEUTICS NOTICE OF THE SGM 1.6 MB

Altamira Therapeutics to Host 1st Half 2023 Financial Results and Business Update Call

Sep 12, 2023 8:00 AM EDT

Altamira Therapeutics to present at H.C. Wainwright 25th Annual Global Investment Conference

Sep 11, 2023 7:00 AM EDT

Meet Altamira: Fly exclusive interview with CEO Thomas Meyer

Aug 10, 2022

Supporting Materials

Altamira Therapeutics Sets Full Year 2021 Earnings Call

Apr 12, 2022 8:00 AM EDT

Supporting Materials

View Presentation 1.7 MB

Altamira Therapeutics to Present at the H.C. Wainwright BioConnect Conference, to be held virtually January 10-13, 2022

Jan 10 - Jan 13, 2022

Altamira Therapeutics to Host Conference Call and Webcast to Provide Business Update on Bentrio™ Program

Sep 27, 2021 2:00 PM CEST

Supporting Materials

Altamira Therapeutics Business Update September 2021 2.4 MB

Altamira Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference, to be held virtually September 13-15, 2021.

Sep 13 - Sep 15, 2021

Pagination

Current page 1
Page 2
Next page
Last page

© Altamira Therapeutics 2024

Imprint | Privacy Notice | Terms of Use